关注并星标CPHI制药在线2015年的“7·22”改革，在当时对国内整个医药行业造成了巨大影响，谁都没想到，十年后的今天，中国的创新药行业迎来了这么美好的时代——群雄并起，群星璀璨，中国正逐渐从传统的制药大国转型为制药强国。无论是临床在研管线数量还是已上市创新药数量，都相较于过去取得了巨大进步。在这其中，离不开资本、政策、临床、医保等多方因素支持。然而，在经历了资本热潮后，国内的创新药行业迎来了...
Source Link关注并星标CPHI制药在线2015年的“7·22”改革，在当时对国内整个医药行业造成了巨大影响，谁都没想到，十年后的今天，中国的创新药行业迎来了这么美好的时代——群雄并起，群星璀璨，中国正逐渐从传统的制药大国转型为制药强国。无论是临床在研管线数量还是已上市创新药数量，都相较于过去取得了巨大进步。在这其中，离不开资本、政策、临床、医保等多方因素支持。然而，在经历了资本热潮后，国内的创新药行业迎来了...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.